Nasdaq

OS Therapies Granted EMA's Advanced Therapy Medicinal Product (ATMP) Designation for OST-HER2 in the Treatment of Pulmonary Recurrence in Resected Osteosarcoma

New York, New York--(Newsfile Corp. - March 25, 2026) - OS Therapies, Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in listeria-based cancer immunotherapies, today ...
Mena FN

Trustvare Releases Advanced OST To PST Conversion Tool With New Features

(MENAFN- Market Press Release) July 5, 2025 1:20 am - TrustVare, a well-known company in IT services, has recently released an OST to PST Converter with additional capabilities. This powerful program ...
Yahoo Finance

OS Therapies Submits Request for Regenerative Medicine Advanced Therapy (RMAT) Designation to U.S. FDA for OST-HER2 in the Prevention of Metastases in Recurrent, Fully-Resected ...

NEW YORK, June 06, 2025--(BUSINESS WIRE)--OS Therapies Inc. (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, ...
Geeky Gadgets

How to Convert Inaccessible OST to PST using Stellar Converter for OST [Detailed Review]

The Stellar Converter for OST software is available to download for free. The free version allows you to convert OST files and save 20 items per folder. Once you discover how easy the conversion ...
Mena FN

OS Therapies Granted EMA's Advanced Therapy Medicinal Product (ATMP) Designation For OST-HER2 In The Treatment Of Pulmonary Recurrence In Resected Osteosarcoma

ATMP benefits include access to the Conditional Marketing Authorisation accelerated market access pathway in Europe, significantly reduced user fees for small and medium-sized enterprises (SMEs), ...